Articles On Telix Pharmaceuticals (ASX:TLX)

The ASX200 has been up 0.06% at 8,414 points. The tech sector has been heavily sold off as global markets respond to the rise of Deepseek, China’s AI startup. Discretionary has been the best performing sector, up 1.2%, followed by Tel...

Telix Pharmaceuticals (ASX:TLX) has joined a somewhat quiet cohort of ASX biotech companies having a pretty good run lately, in some cases outperforming just about everything else. (Just think: Mesoblast, Orthocell, Clarity Pharmaceutica...

The S&P/ASX 200 Index (ASX: XJO) has fought back from a poor start and is pushing higher. In early afternoon trade, the benchmark index is up 0.2% to 8,425.7 points. Four ASX shares that are rising more than most today are listed below...

The ASX 200 is rumbling back to life after the Australia Day long weekend and investors are pushing the bourse up by over 37.9 points already. The 0.45% rise, to around 8,417 points, stands in defiance to the tech rout Wall Street suffer...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin MELBOURNE, Australia and INDIANAPOLIS, Jan. 28, 2025 /PRNewswire/ — Telix Pharmac...

The S&P/ASX 200 Index (ASX: XJO) is down 0.7% in early afternoon trade on Thursday, but that's not keeping these four ASX 200 shares from leaping to new 52-week highs. Two of the outperforming companies operate in the healthcare spa...

Viewed as a ‘mini me’ version of the all-conquering Telix Pharmaceuticals, the $60 million market cap Radiopharm Theranostics (ASX:RAD) is emerging from unloved status to that of a genuine contender in the red-hot radiopharmaceutical sector...

The ASX200 closed down 0.2% at 8,310 points. China’s latest economic data beat estimates. GDP growth accelerated to 5.4 per cent year-over-year for the December quarter, up from 4.6 per cent in the September quarter and well above con...

Banks fall, mining stocks rise Rio Tinto in mega merger talks, suggests Bloomberg China hits 5pc growth but property struggles   After a day of zigzagging, the ASX closed lower by 0.2% on Friday as losses in the financials and comms secto...

Announced today, Melbourne-based biotech Telix Pharmaceuticals (ASX: TLX) is a step closer to launching its prostate cancer diagnostic agent Illuccix in Europe after securing authorisation for its commercial distribution. The company annou...

Highlights  Commonwealth Bank (ASX:CBA) drags down ASX after major losses.  Lovisa (ASX:LOV) jumps 8% following an upgrade to “overweight” rating.  Lynas Rare Earths (ASX:LYC) dips 2.2% due to slower production.  On Friday afterno...

After the ASX’s strong performance in 2024, optimism is building as we shift our focus to what 2025 has in store. The New Year brings renewed energy, exciting opportunities, and the promise of growth. But the big question is: will the marke...

Highlights  S&P/ASX 200 index remains flat at midday.  Rio Tinto (ASX:RIO) slips, while Insignia Financial (ASX:IFL) rises after a bid increase.  Lynas Rare Earths (ASX:LYC) sees a dip following production slowdown.  Australia...

In early afternoon trade, the S&P/ASX 200 Index (ASX: XJO) is on course to record a small gain. At the time of writing, the benchmark index is up slightly to 8,330.3 points. Four ASX shares that are rising more than most today are list...

Pic via Getty ImagesRadiopharmaceuticals company Telix reports sustained revenue growth in Q4 FY24 ASX health stocks fall about 2.8% over past week Neuren’s partner Acadia submits marketing authorisation application in Europe for trofine...

Telix Pharmaceuticals Ltd (ASX: TLX) shares are ending the week on a positive note. In morning trade on Friday, the ASX 200 healthcare stock is up 4.5% to a record high of $27.00. Why is this ASX 200 healthcare stock racing higher? Investor...

It was a day of relief and optimism for the S&P/ASX 200 Index (ASX: XJO)  and ASX investors this Tuesday. After several days of sometimes nasty drops, investors turned the ship around today....

The ASX200 pared early gains and closed up 0.48% at 8,231 points. A lift in the iron ore price has driven big miners higher; Fortescue was the biggest winner, up 2.7%, followed by BHP, up 1.4% and Rio Tinto, up 0.8%. The Materials sec...

Highlights  The Australian sharemarket gains with positive movement across multiple sectors.  Energy stocks rise with Brent crude, while mining giants benefit from iron ore price increases.  The Star (SGR) rises sharply as a mystery i...

The S&P/ASX 200 Index (ASX: XJO) is back on form and pushing higher. At the time of writing, the benchmark index is up 0.3% to 8,215.2 points. Four ASX shares that are rising more than most today are listed below. Here's why they are c...

Highlights  ASX rebounds, led by energy and mining sectors.  City Chic (CCX) surges nearly 20% on holiday sales.  Telix Pharmaceuticals (TLX) posts significant revenue growth.  The Australian share market started strong, reboundin...

The Telix Pharmaceuticals Ltd (ASX: TLX) share price is roaring higher on Tuesday morning. At the time of writing, the ASX 200 share is up 7% to $25.79. Why is this ASX 200 share jumping? Investors have been buying the company's shares this...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin World Overnight SPI Overnight 8211.00 + 40.00 0.49% S&P ASX 200 8191.90 –...

After a downturn to start Week 3, things look to be turning around in Australia with ASX 200 futures pointing to a 0.5% rise – a gain of around 40 points – today. Though it’s still under enormous pressure, the Aussie dollar ticked up sli...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin MELBOURNE, Australia and INDIANAPOLIS, Jan. 14, 2025 /PRNewswire/ — Telix Pharmac...

Were you invested in ASX 200 shares vs. property last year? Let's examine which S&P/ASX 200 Index (ASX: XJO) companies experienced the best share price growth and which suburban property markets delivered the best capital gains for...

On Monday, the S&P/ASX 200 Index (ASX: XJO) started the week in a disappointing fashion. The benchmark index sank 1.2% to 8,191.9 points. Will the market be able to bounce back from this on Tuesday? Here are five things to watch: ASX...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin MELBOURNE, Australia and INDIANAPOLIS, Jan. 13, 2025 /PRNewswire/ — Telix Pharmac...

Telix enters into asset purchase agreement with antibody engineering company ImaginAb Lumos joins forces with MedPro for national contract sales coverage of FebriDx in US  4D Medical secures US Department of Defense contract to supply C...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin MELBOURNE, Australia and LIÈGE, Belgium, Jan. 13, 2025 /PRNewswire/ — Telix Pharm...

Melbourne-based biotech Telix Pharmaceuticals (ASX: TLX) is planning to expand its suite of next-generation drug candidates through the acquisition of US-based antibody engineering company ImaginAb for US$45 million ($73 million). The deal...

The Aussie market has kicked off the week lower after an unexpected jump in new U.S. jobs jettisoned any near-term hopes of a rate cut by the Fed Reserve. Back home, jobs ads rose by just 0.3%, having a negligible impact on the bourse....

S&P/ASX 200 Index (ASX: XJO) healthcare stock Telix Pharmaceuticals Ltd (ASX: TLX) is slipping today. Shares in the diagnostic and therapeutic product developer closed on Friday trading for $23.99. In morning trade on Monday, shares...

Telix Pharmaceuticals Ltd (ASX:TLX) is adding to its portfolio of early-stage drug candidates, in addition to a suite of other assets, through a $73 million asset buy agreement with antibody engineering company ImaginAb, Inc. A further $...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin MELBOURNE, Australia and INDIANAPOLIS, Jan. 13, 2025 /PRNewswire/ — Telix Pharmac...

S&P/ASX All Ordinaries Index (ASX: XAO) shares rose by 7.55% last year and delivered total gross returns, including dividends, of 11.44%. The index closed the year at 8,420.5 points. In comparison, the benchmark S&P/ASX 200 Inde...

Let's look back and see which ASX shares vs. property markets delivered the best capital gains in 2024. Shall we start with stocks? ASX 200 shares up more than 7% in 2024 The benchmark S&P/ASX 200 Index (ASX: XJO) lifted 7.49...

Ausbiotech is developing a pre-budget wish list to tackle the sector’s “stubborn issues” CEO Bek Cassidy says the sector’s record at commercialising products is better than portrayed, but it still needs some help. No fewer than 2900 organi...

ASX 200 healthcare shares performed well in 2024, with the S&P/ASX 200 Health Care Index (ASX: XHJ) rising 6.01% and delivering a 12-month total return, including dividends, of 7.51%. However, the healthcare sector did underperform t...

The Vanguard Australian Shares Index ETF (ASX: VAS) delivered a total gross return of 11.4% in 2024. This comprised approximately 7.75% in capital growth and a dividend yield of about 3.65%, excluding franking credits, based on prelimin...

Highlights Market Movements: ASX futures indicate a 0.9% decline; global markets see subdued activity due to New Year closures. Top and Bottom Performers: Key ASX gainers include Zip Co (ASX: ZIP) with a 363% surge, while Liontown Re...

The S&P/ASX 200 Index (ASX: XJO) was on form in 2024 and rose approximately 7.5% to 8,159.1 points. And including dividends, the benchmark index delivered a return in the region of 11.2%. While this is a strong return and ahead of his...

The ASX is barrelling towards closing out 2024 with another red day on New Year’s Eve, but that doesn’t mean the year as a whole was a bloodbath – in fact, for much of the Aussie index it’s been quite the year to remember. Even more so,...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin MELBOURNE, Australia and BRUSSELS, Dec. 31, 2024 /PRNewswire/ — Telix Pharmaceu...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin MELBOURNE, Australia and INDIANAPOLIS, Dec. 30, 2024 /PRNewswire/ — Telix Pharmac...

On Friday, the S&P/ASX 200 Index (ASX: XJO) finished the week on a positive note. The benchmark index rose 0.5% to 8,261.8 points. Will the market be able to build on this on Monday? Here are five things to watch: ASX 200 expected to...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin MELBOURNE, Australia and INDIANAPOLIS, Dec. 19, 2024 /PRNewswire/ — Telix Pharmac...

It was a bit of a disappointing hump day session for the S&P/ASX 200 Index (ASX: XJO) this Wednesday. After spending most of the morning in green territory, investors got cold feet a...

It was a fairly nasty start to the trading week for the S&P/ASX 200 Index (ASX: XJO) and many ASX shares this Monday. After a rough week last week, investors clearly didn't get their m...

Anteris shares have commenced trading on the Nasdaq exchange 4D Medical snags another US lung imaging contract Anatara reports more than enough irritable bowel trial takers   Shares in heart valve innovator Anteris Technologies (ASX:AVR...